What's breaking now, across thousands of outlets.
Eli Lilly is the leader in the GLP-1 space, but not every new drug the company is working on will be a winner.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
The FDA approved AbbVie’s next-generation therapy for Parkinson’s disease, tavapadon, a dopamine agonist that's expected to provide the symptom relief of its predecessors but with fewer side effects.
(MedPage Today) -- A 12-year-old boy arrives in the pediatric emergency department wincing with right lower quadrant pain.
com. While many people look forward to the Chuseok holiday, some worry about what they will see on the scale, with generous servings of "jeon," or pan-fried battered dishes, braised short ribs…
Ukraine has received $51.5 million from the Japanese government under the World Bank’s THRIVE project to support the country’s healthcare system, Prime Minister Serhii Koretskyi said on September 26…
The FDA said that consumers should return the recalled products to where they bought them for a refund.
Punjab has decided to provide body cameras to drug inspectors in an effort to improve monitoring and address complaints more … Read More The post Punjab Orders Drug Inspectors to Wear Body Cameras…
